S’identifier Contacter
Demander une démonstration
mars 15, 2022

Latest release of Philips Capsule Surveillance receives FDA clearance

  • Clinical surveillance solution is designed to identify emergent patient deterioration and offer enhanced patient data visibility, flexible viewing options, and clinical decision support
  • Facilitates remote patient oversightat mobile, eICU and virtual care clinical touchpoints
  • New FDA clearance covers additional use cases and information access methods

Amsterdam, the Netherlands—Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced today at HIMSS22 that the latest Philips Capsule Surveillance solution has received 510(k) market clearance from the U.S. Food & Drug Administration (FDA), paving the way for widespread deployment across healthcare systems in the USA.

Read the full press release